<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01441336</url>
  </required_header>
  <id_info>
    <org_study_id>SNUBHGS02</org_study_id>
    <nct_id>NCT01441336</nct_id>
  </id_info>
  <brief_title>Laparoscopic Gastrectomy for Advanced Gastric Cancer</brief_title>
  <official_title>Laparoscopic Gastrectomy for Advanced Gastric Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Bundang Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Although laparoscopic gastrectomy (LG) is widely used for the treatment of early gastric
      cancer, there have been few reports of the efficacy of LAG in the management of advanced
      gastric cancer(AGC). The aim of this study is to evaluate the surgical outcomes and oncologic
      safety of laparoscopic gastrectomy for AGC.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective phase II clinical trial to evaluate technical and oncological safety of LG for
      AGC

      LG procedure for AGC:

      D2 lymphadenectomy Total omentectomy for tumor with serosa exposure under laparoscopic
      exploration

      Primary end point: 3 year disease free survival secondary end point: postoperative outcomes,
      morbidity and mortality, 3,5 and 7 year overall survival, Quality of life, recurrence pattern

      Study duration: 7 years(enrollment: 4year, follow-up: 3year)
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2008</start_date>
  <completion_date type="Actual">July 2015</completion_date>
  <primary_completion_date type="Actual">July 2012</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>3 year recurrence free survival</measure>
    <time_frame>Postoperative 3 year</time_frame>
    <description>Evaluation of recurrence after regular 3 months follow-up using tumor marker, chest x-ray, endoscopy and computed tomograhy.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">204</enrollment>
  <condition>Advanced Gastric Cancer</condition>
  <condition>Laparoscopic Gastrectomy</condition>
  <arm_group>
    <arm_group_label>Laparoscopic gastrectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Laparoscopic gastrectomy procedure:
D2 lymphadenectomy &amp; total omentectomy in case of tumor with serosa exposure under laparoscopic exploration</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic gastrectomy</intervention_name>
    <description>Operative procedure: laparoscopic gastrectomy(D2 lymphadenectomy according to JGCA guideline and total omentectomy for tumor with serosa exposure)</description>
    <arm_group_label>Laparoscopic gastrectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 20-80

          -  informed consent

          -  no other malignancies

          -  cT2N0-cT3N2 according to JGCA 2nd edition

          -  ASA score&lt;3

        Exclusion Criteria:

          -  distant metastasis(P1 or M1) under laparoscopic exploration

          -  Conglomerated N2

          -  early gastric cancer in permanent pathologic report
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam</city>
        <state>Gyeonggi</state>
        <zip>463-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 25, 2011</study_first_submitted>
  <study_first_submitted_qc>September 25, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 27, 2011</study_first_posted>
  <last_update_submitted>January 6, 2017</last_update_submitted>
  <last_update_submitted_qc>January 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Bundang Hospital</investigator_affiliation>
    <investigator_full_name>Hyung-Ho Kim</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

